Between 15 and 40% of cancer patients develop clinical anxiety and/or depression (Derogatis et al, 1983; Massie and Holland, 1990; Parle et al, 1996) . Even for those ostensibly cured the prevalence remains appreciably higher than that of the general population a year or more after diagnosis (Devlen et al, 1987) . This evidence, combined with significant pressure from service users, has led to increasing provision of psychological interventions in British oncology services. This has been piecemeal (Fallowfield, 1988) and guided more by local factors than evidence of efficacy. There is little evidence based consensus about optimal methods of intervention, appropriate standards for clinical practice and training, or whether service provision is best directed towards prevention or the treatment of disorder (Fallowfield and Roberts, 1992; Hopwood and Maguire, 1992; Brennan and Sheard, 1994) .
Inclusion and exclusion criteria Trials were included if they (a) evaluated psychosocial or psychiatric interventions aimed specifically at alleviating psychological distress in oncology subjects, (but excluded if the main focus was the reduction of physical symptoms, prolongation of survival, impact on immune parameters or reduction of peri-surgical distress); (b) had a control condition; and (c) had been published in a journal or indexed as a dissertation before January 1993 when this project was initiated. Resource constraints limited inclusion of trials to those available in an English language form through British library services.
Single group designs (i.e. those without a control group) were excluded. Restricting eligibility to randomized control trials was considered but at present evidence from psychotherapy metaanalyses suggests that randomization does not affect outcome. Lipsey and Wilson (1993) in their meta-analysis of 136 metaanalyses of psychological interventions identified only three factors which significantly influenced size of effect: single group designs (i.e. those with no control group) and small sample size trials had larger effects (publication bias), while placebocontrolled trials had smaller effects. The possible influence of different aspects of trial quality on our meta-analyses are explored in a sensitivity analysis. Excluding non-randomized trials would also have the disadvantage of reducing the representativeness of the sample and the statistical power.
Coding
Data from published and unpublished reports were entered on a standardized coding form which included criteria for assessing and coding ambiguous information. Study features were coded under specific domains: independent variable (e.g. type of therapy, 'dose' of therapy), subject (e.g. prognosis) and setting variables, experimental method, dependent variables (i.e. anxiety and depression), and quality of reporting. A system for scoring aspects of study methodology was devised based on Cook and Campbell's (1979) four categories of threats to validity (available on request). Studies which used more reliable methods were identified using three factors: (i) use of randomization, (ii) falling into the top 75% on overall quality score, and (iii) sample size greater than 40.
Results were coded for 'post-tests' (outcomes measured immediately after completing the intervention) when performed, or for observations taken between 3 and 6 months after commencement of flexible length interventions.
Outcome measures
For those trials using more than one anxiety or depression measure the result from only one instrument was selected to represent each domain. Commonly used measures were selected preferentially to increase comparability. Failing this, the data from the instrument with superior psychometric properties were included, or if this was similar, selection was random.
Statistical methods
Effect sizes for continuous psychological data are normally represented in terms of standard deviation shift; thus a positive value represents a better outcome for the intervention group. Where possible the effect size 'g' was estimated as a standardized mean difference: this is the mean value for the intervention group minus mean value for control group divided by their pooled standard deviation. For studies not providing this data 'g' was estimated from precise statistical test values (Hedges and Olkin, 1985) . Hedges and Olkin (1985) have shown that 'g' has a small sample bias, this is corrected into the unbiased estimator 'd' which is very similar to 'g' for large studies but smaller in small studies. Confidence intervals for the effect sizes of individual studies were based on estimates of conditional variance as given by Hedges and Olkin (1995) . Prof R Schwarzer's meta-analysis programme was used (Frei Universitat Berlin, Germany).
In view of the broad entry criteria, descriptive focus and an expectation of considerable heterogeneity the more conservative random effects analysis was used (Cook and Campbell, 1979; Raudenbush, 1994) both in estimation of main effects and in exploration of the moderating effect of variables which were hypothesized to affect outcome (such as the amount of therapy given, the therapists' level of training and experience, or cancer prognosis). Fixed and random effects models address the problem of heterogeneity in different ways and have complementary strengths and shortcomings (Cook and Campbell, 1979; Thompson, 1993) . Estimates of the main effects obtained using these models are compared in a sensitivity analysis.
Tests for interaction were used to see whether there was evidence of different size of effect in two or more groups. This was achieved by subtracting the sum of Q's (homogeneity statistics) for individual groups from the Q for the individual groups combined. This yields a χ 2 value with nϪ1 degrees of freedom where n is the number of groups.
Publication bias (the tendency for only studies with statistically significant results to be accepted for publication) presents a considerable threat to the representativeness of meta-analysis samples. This was estimated using three methods. The effect sizes for published and unpublished studies were compared, a smaller mean effect size for unpublished studies would be an indicator of publication bias. Funnel plots of sample size against effect size indicate if small sample size trials are inadequately represented Table 1 Trials used in the meta-analyses Anxiety meta-analysis only Carpenter, 1984 Cumbia, 1985 Davis, 1986 Golonka, 1976 Johnson, 1982 Depression meta-analysis only Guerrant, 1984 Hayes, 1981 Linn et al, 1982 Price, 1982 West, 1980 Youssef, 1984 Anxiety and depression meta-analyses Bindemann et al, 1991 Bloom et al, 1978 Cain et al, 1986 Christensen, 1983 Decker et al, 1992 Fawzy et al, 1990 Frankel, 1985 Greer et al, 1992 Houts et al, 1986 Hurst, 1986 Maguire et al, 1980 Spiegel et al, 1981 Telch and Telch, 1986 Worden and Weisman, 1984 while Rosenthal's (1979) 'fail safe n' indicates the number of unpublished studies of effect size zero locked away in researchers' filing cabinets which would be required to reduce the mean effect size to a specific level.
For those studies comparing two different interventions with a common control group the intervention groups' effect sizes are not independent and therefore the data for the less structured intervention arms were eliminated (e.g. in a comparison of a coping skills intervention with simple support the support arm was eliminated (Telch and Telch, 1986) ).
RESULTS
Anxiety was used as an outcome measure in 19 studies, depression in 20 and 14 studies were common to the two meta-analyses (Table 1) . Five trials (Worden and Weisman, 1984; Cumbia, 1985; Cain et al, 1986; Davis, 1986; Telch and Telch, 1986 ) compared two types of intervention with a common control. Only three studies (Maguire et al, 1980; Bindemann et al, 1991; Greer et al, 1992) , all of individual therapy, were conducted outside of the US, many were conducted in university hospitals and the samples were generally skewed towards whites, the well-educated, women and a diagnosis of breast cancer. Inclusion criteria were largely medical rather than psychological. The majority of trials were preventative in orientation: only three anxiety (Worden and Weisman, 1984; Telch and Telch, 1986; Greer et al, 1992) and four depression trials (West, 1980; Worden and Weisman, 1984; Telch and Telch, 1986; Greer et al, 1992) restricted inclusion to those identified as being at risk of, or suffering, significant psychological distress. In other trials subjects were recruited sequentially on the basis of a cancer diagnosis, or on referral by an oncologist, or were self-selected. The analyses of the anxiety and depression data are presented separately. Table 1 lists the references included in the anxiety and/or depression meta-analyses.
Anxiety meta-analysis
Nineteen trials were included (Table 1) . A total of 26 trials were identified measuring anxiety and met initial entry criteria, but six were excluded as effect sizes could not be estimated (Table 2 ). Figure 1 shows the spread and confidence intervals for the 19 studies. The total sample size is 1023, the combined effect size is 0.42 and the dataset is strongly heterogeneous. Nine trials used the Profile of Mood States (POMS) (McNair et al, 1971 ) tension subscale as a measure of anxiety, five used the Spielberger State Anxiety Inventory (Spielberger et al, 1983) , and the remaining five used other measures.
Sensitivity Analysis (Table 2 and Figure 2 ) Table 2 summarizes trials excluded from both meta-analyses. It was possible in some cases to gain an indication of the magnitude A very approximate estimate of effect size was obtained by (a) calculating effect sizes from data from selectively presented outcomes and adjusting this down according to the extent of incompletely reported data for other outcomes, (b) noting when outcomes hardly differed between treatment and control groups, (c) assuming small effect sizes in trials which had statistically non-significant results despite a large sample. *Low scores for distress at baseline and follow-up in treatment and control groups and therefore treatment effect not demonstrable.
of effect in the excluded studies. Inclusion of two (Gordon et al, 1980; Bridge et al, 1988 ) might have reduced the mean effect size for anxiety (see second last column Table 2 ).
Two extreme positive outliers stand out in Figure 1 (Johnson, 1982; Telch and Telch, 1986) and have a combined sample size of 79. Removal of these reduces the effect size by a third to 0.27 ( Figure 2 ).
There are indications that the use of randomization and other features contributing to greater reliability in design are associated with larger effects (Figure 2 ). Fifteen studies used randomization to determine allocation to condition and these have a greater combined effect size than the four non-randomized studies (0.5 vs 0.19). Eight studies met our criteria for greater reliability and these have a greater mean effect size than the 11 studies of less reliable design (0.63 vs 0.24). This difference is not attributable to the two extreme positive outliers as one fell into each group. Removing the one positive outlier (effect size 2.6, sample size 52) (Johnson, 1982) from the group of 11 trials of more reliable design reduces the effect size by nearly 50% to 0.36 (95% CI 0.095-0.63). Decker Greer 1976 1978 1980 1991 1992 1992 The data from this sample suggest bias in the published subsample: published studies (n = 14) have a mean effect size of 0.51, compared to 0.16 for unpublished theses (n = 5). However, including the unpublished theses in a funnel plot results in a reasonably symmetrical distribution. Applying Rosenthal's 'fail safe n' indicates that 20 undetected studies of effect size zero are required to reduce the effect size to 0.2 (0.2 is a level generally regarded as representing a clinically weak to negligible effect for psychological interventions).
The larger effect size found using the usually more conservative random effects compared to the fixed effects analysis is difficult to explain as a correction is made for small sample size bias. Wider confidence intervals are expected for the random effects analysis as they include estimates both of between and within study sampling variation.
Variables influencing effects (Figures 3 and 4)
The marked heterogeneity of the data supported a preliminary Figure 4 Dose, therapist and subject variables: anxiety exploration of the possible moderating effect of clinically relevant variables. This was done using hypotheses formed before beginning the data analysis. Contrary to prediction interventions delivered in an individual format had an effect size similar to relaxation alone and only approximately 50% that of interventions in a group format (P = 0.0076). Three trials of groups psychoeducational courses (Johnson, 1982; Telch and Telch, 1986; Fawzy et al, 1996) had a considerably larger mean effect than other group interventions (P = 0.0005). This subgroup almost entirely accounts for the difference in effect size between group and individual interventions ( Figure 3) ; it also contains both of the positive outliers. ( Figure 4 ) must be viewed with considerable caution as they are based only on those studies, on occasion a small minority, which actually specified them and therefore cannot be taken as representative of the sample. The data suggest a dose-response effect (P = 0.0017) which is unlikely to be due to a maturation confound as interventions given over a 6-week or shorter period actually have a marginally greater effect size (0.6) than those taking longer than 6 weeks (0.52). The use of more experienced therapists is associated with a larger effect but this falls just below the 5% level (P = 0.054). Effects were preserved at follow-up in the small minority (n = 4) of trials which examined this important outcome at a variety of time points beyond the end of the intervention (Cain Davis, 1986; Fawzy et al, 1990; Greer et al, 1992) . Unfortunately there was insufficient data available to explore the potentially important influence of the timing of the commencement of interventions relative to diagnosis, relapse and treatment.
Depression meta-analysis
Twenty trials were included (see Table 1 ). A total of 30 trials were identified which measured depression and met initial entry criteria, but ten were excluded as effect sizes could not be estimated (Table 2 ). Figure 5 shows the spread and confidence intervals for the 20 trials. The total sample size is 1101, the combined effect size is 0.36 and the dataset is strongly heterogeneous. Twelve depression effect sizes were measured using the Profile of Mood States (POMS) depression subscale (McNair et al, 1971) , five using the Beck Depression Inventory (Beck and Steer, 1987) and three used other measures. Figure 6 ) The ten excluded studies are summarized in Table 2 . Inclusion of four (Farash, 1977; Gordon et al, 1980; Bridge et al, 1988; Burton and Parker, 1988) would probably have reduced the mean effect size, while inclusion of one (Watson et al, 1988) would have increased it.
Sensitivity analysis (Table 2 and
Removal of three positive outliers (West, 1980; Youssef, 1984; Telch and Telch, 1986 ) with a total sample size of 59 reduces the overall effect by a half to 0.19 ( Figure 6 ).
The use of randomization did not appear to influence effect: the 14 randomized trials have a very similar combined effect size to the six non-randomized trials (0.38 vs 0.31). Superior study quality appears to be associated with weaker effects (Figure 2 ): eight studies meeting the criteria for more reliable design have a smaller mean effect size than 12 less reliable studies (0.21 vs 0.50). However, this difference is entirely attributable to the three positive outliers falling into the unreliable design group. Their elimination reduces the combined effect size for this group to 0.18, equivalent to the 0.21 value for the more reliable studies.
Publication bias does not appear to be a feature of the published subsample as these trials have very similar mean effect sizes to the unpublished trials even with one unpublished small sample size extreme positive outlier (West, 1980) removed. A funnel plot does not show a skewed distribution. Sixteen unpublished studies with an effect size of zero hidden in researchers' filing cabinets are required to reduce the mean effect size to 0.2.
Variables influencing effects (Figures 7 and 8)
The marked heterogeneity of the data supported a preliminary exploration of the possible moderating effect of clinically relevant variables. As for the anxiety data-set individual interventions have a smaller effect size than group interventions but for depression this difference is not statistically significant. The two trials of relaxation have an aggregate effect size of zero, one had a positive effect (Bindemann et al, 1991) , one a negative effect (Decker et al, 1992) .
Again the findings for other variables which might influence effect must be viewed with considerable caution as they represent data only from those studies which actually specified them. As for anxiety a larger effect size is associated with higher therapist level of training and experience in oncology (P = 0.0375 with one very small sample size extreme outlier removed (West, 1980) ). Effect size is greater for those with advanced disease (P = 0.0327). Only three trials included follow-up measures (Halttunen et al, 1992) , mean effect at post-test (0.27) was at least sustained at follow-up (0.49).
DISCUSSION
As expected the included trials show considerable variation in subjects, settings, intervention modality, theoretical base, therapist expertise, amount of therapy given and experimental methods. This clinical marked heterogeneity suggests that the emphasis in these meta-analyses should be on the main effects, in particular their clinical significance and robustness.
The anxiety main effect of 0.42 can be taken to be fairly robust. Publication bias in the published sub-sample appears to have been corrected by inclusion of unpublished theses which had smaller effects and sample sizes. Twenty unpublished trials of zero effect size would be required to produce a 50% reduction in effect size. Inclusion of the seven studies which were excluded because of missing data would most probably have had very little impact on the combined effect size. The main threat to robustness appears to be the large influence of two positive outliers with a combined sample size of 79. Removing them renders the overall effect much smaller and of marginal clinical significance. However, trials with more reliable design have a moderate to strong effect size of 0.63. Only one of the extreme positive outliers falls into this group and its removal reduces the effect size down to 0.36; this is comparable with, but slightly less than the overall effect size of 0.42 for all 19 anxiety studies. This value of 0.36, based on the ten of the 19 trials of most reliable design, can be taken to be the most robust summary statistic for the anxiety trials.
Normative data for the Spielberger State Anxiety Inventory (STAI), which was used in five of the 19 trials, give some indication of the clinical significance of these anxiety effect sizes. A 0.36 standard deviation shift for the STAI is approximately equivalent to the difference between the anxiety levels of normal subjects and that of general medical and surgical in-patients (Spielberger et al, 1983) .
The depression main effect of 0.36 is not as robust as that for anxiety: there is no evidence of publication bias but including only those trials with more reliable design decreases it by nearly 50% to 0.21. Similarly, eliminating the three extreme positive outliers (which all fall into the less reliable design subgroup) reduces the mean effect to 0.19. Also inclusion of the trials excluded through missing data (Table 2) would also probably reduce the mean effect. The Beck Depression Inventory (BDI) was used in five of the 20 depression trials; for the BDI a 0.36 standard deviation shift approximates to 50% (and 0.21 standard deviation to 30%) of the difference between the means of moderate and mild depression (Beck et al, 1961) , but a 0.21, or 0.19 shift is little more than half of this and of very doubtful clinical significance. In summary, the main effect for anxiety can be taken to be of moderate clinical significance, that for depression as weak to negligible.
The clinically significant effect for anxiety but not depression may in part be attributable to the well-established finding that the prevalence of anxiety in oncology populations is greater than that for depression (Parle et al, 1996) . Prevalence is relevant in this case as the great majority of both the anxiety and depression trials in this sample were preventative in nature, i.e. the subjects were not selected on psychological criteria. This preventative orientation is a very important feature of the trials included in these two meta-analyses; the majority of trials recruited subjects on the basis of a diagnosis of cancer, or being thought suitable for inclusion by an oncologist, or being self-referred. Consequently, a large proportion of the individuals receiving an intervention may have neither needed nor benefited from it. This would substantially reduce effect size and indeed the mean effect even for anxiety is only about 50% of the mean effect of 0.69 found in a meta-analysis of trials of psychotherapy for depression (Robinson et al, 1990 ) (not cancer patients). However, the anxiety effect is not a great deal smaller than the overall mean of 0.5 found by Lipsey and Wilson (1993) in their meta-analysis of meta-analyses of psychological interventions in many settings. Also four meta-analyses of antidepressants for depression have reported effect sizes between 0.19 and 0.79 (Smith et al, 1980; Shapiro and Shapiro, 1982; Quality Assurance Project, 1983; Steinbrueck et al, 1983; Greenberg et al, 1992) .
Unfortunately, only four trials specifically recruited subjects identified as either suffering from, or at high risk of, significant psychological distress (Linn et al, 1982; Worden and Weisman, 1984; Telch and Telch 1986; Greer et al, 1992) . The effect sizes for screened subjects are large and similar for anxiety (0.94, n = 3) and depression (0.85, n = 4). For non-screened subjects the anxiety effect size is moderate to weak (0.33) but again the depression effect size is small and clinically insignificant (0.16) (Figure 4 and 8). These differences are not statisticaly significant at the 5% level, but the statistical power is low. More data is needed on the effectiveness of psychological interventions with cancer patients who are identified as either suffering from, or at risk of significant psychological distress.
The effect size for the anxiety meta-analysis is appreciably greater than that of 0.24 found by Meyer and Mark (1995) in their less focused fixed effects meta-analysis of 45 published trials of psychological interventions in oncology. Their sample included a wide range of psychological, educational or nursing interventions aimed at altering an extremely broad range of outcomes which included pain or treatment side-effects, psychological distress, identified problems and quality of life. The effect size of 0.24 was an average of any psychological outcome measures made in this disparate set of trials. We compared our samples with theirs: Meyer and Mark (1995) included only 11 of our 16 published trials (and by definition none of our nine unpublished trials), and only one (80) of our ten trials (two unpublished) excluded because of missing data. They did not appear to have identified any trials unknown to us. Meyer and Mark's findings are therefore based on a sample which is 75% different from ours, less focused in terms of trial aims and outcomes, and which appears to be less representative of the literature. Most of the difference in findings could be attributed to these factors.
Examination of extreme outliers is important as they may represent an important subset with particular features in common which account for their distance from the mean. For anxiety there are two obvious positive outliers which are both trials of group psychoeducational courses (Johnson, 1982; Telch and Telch, 1986) . This type of intervention has a large mean effect size of 1.59 (n = 3 trials, total sample size 145) compared with 0.27 found for other group interventions. There was no obvious pattern to the three depression-positive outliers which consisted of trials of group therapy (Capone et al, 1980) , of a group psycho-educational course (69) and individual cognitive therapy (Linn et al, 1982) . There were no obvious negative outliers, but six anxiety and three depression trials did have negative effect sizes. This statistical variation is expected but the majority of these trials also had features which made a negative finding more likely.
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Interaction effects
Exploration of the effect of therapy type produced unexpected findings (Figures 3 and 7) . The large effects found for the few trials of group psycho-educational courses for both anxiety and depression are impressive but require replication. The equivalent effect of group and individual therapy (after subtraction of group psycho-educational courses) was contrary to prediction and contrasts with Shapiro and Shapiro's meta-analysis of psychotherapy which found individual therapy to be more effective than group (Shapiro and Shapiro, 1982) . This unusual finding could be a reflection of cancer patients having a shared predicament. The data on relaxation are sparse but as predicted there was an effect on anxiety but not depression. The influence of other hypothesized moderator variables is only suggestive and is presented (Figures 4 and 8) mainly as a potential basis for hypothesis generation for future trials or explanatory meta-analyses. The numbers of studies in some subgroups are extremely small but the results are strengthened by their being very largely in the expected direction.
The findings have considerable clinical and service implications:
i. These data can help inform the problem of where best to direct limited clinical resources. The results indicate that preventative routine psychological intervention for all cancer patients will at best have a clinically moderate effect on anxiety, but a negligible one on depression. Resources are scarce and therefore it is likely that clinically powerful and therefore costeffective outcomes for anxiety and depression are only likely to result in interventions targeted at those suffering from or at risk of significant psychological distress. However, only four out of the 25 trials in the two meta-analyses intervened specifically on such patients. More trials of this kind are needed to establish whether they reliably result in clinically strong effects.
ii. Group therapy appears equally effective to individual, or perhaps considerably more so in the case of group psychoeducational courses. Group therapy is clearly cheaper to provide but the group therapy data are exclusively North American and therefore replication in the very different European cultural and health service context is required.
iii. There is evidence to suggest that relatively short but intensive interventions delivered by experienced and more highly trained therapists are more effective than more protracted interventions offered by less psychologically trained staff. It is possible that interventions of longer duration carry the risk of over-sensitizing subjects to their status as cancer patients, leading them to doubt their ability to cope without professional support (Maguire et al, 1980) . However, more data are required on longer term outcome.
1 Three trials were common to the anxiety and depression samples and the negative effect can be attributed to the intervention groups being considerably more distressed at baseline (Bloom et al, 1978; Davis, 1986; Decker et al, 1992) . In the other three anxiety trials one used a post-test only design (Cumbia, 1985) , one was an evaluation of the effect of a brief telephone intervention given to subjects already receiving a psychosocial care programme (Houts et al, 1986) , and one had no features that might obviously account for the intervention group faring worse than the controls (Hurst, 1986) .
